INS and type 2 diabetes mellitus: In the RELIEF study, using the French national health claims database, hospitalisation for hypoglycaemia over the 2 year study period was reduced both for people with type 2 diabetes on any therapy (43% fewer admissions), of whom 85% were on intensive insulin therapy [37], but also for the smaller subgroup with type 2 diabetes on basal insulin only (44% fewer admissions) [38].